Browse By:

Friday October 19, 2018 Login |Register

A Project of

sponsored by

The Benefits to State Governments from the Free Market Drug Act

Bookmark and Share Report Misuse or Glitches

Publication Date: November 2004

Publisher(s): Center for Economic and Policy Research

Author(s): Dean Baker

Topic: Health (Pharmaceutical services)

Keywords: Prescription drugs; Biomedical research; Public domain

Type: Report

Coverage: United States


This study’s projections show that all states would see substantial savings under the Free Market Drug Act, a proposal to directly fund drug research and allow all new drugs to be sold as generics. The biggest winners would be New York, California and Texas. Over the years 2009 to 2013, these states would save $9.3 billion, $7.1 billion, and $3.7 billion, respectively.